Chasing the Paradigm: Clinical Translation of 25 Years of Tissue Engineering.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30727841.
- Also identified by DOI 10.1089/ten.TEA.2019.0032 and PMC identifier 6533781.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this Perspective, we discuss the impact of the past 25 years of tissue engineering on the development of clinical therapies. Based on their success and other significant research accomplishments, platforms of innovation were identified. Their discoveries will enable tissue engineering inspired therapies to meet the requirements necessary for large-scale manufacturing and Food and Drug Administration (FDA) approval for a diverse range of indications.
Medical subject headings
- Bioprinting
- Printing, Three-Dimensional
- Regenerative Medicine
- Tissue Engineering
- Tissue Scaffolds